T1	Limited_variation	60 79	MMP-2 polymorphisms
T2	Pharmacodynamic_phenotype	85 107	treatment efficacy and
T3	Disease	126 144	severe toxicity in
T4	Disease	159 203	nonsmall cell lung cancer ( NSCLC ) who were
T5	Chemical	227 257	platinum -based chemotherapy .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T2	Arg2:T1
R6	isAssociatedWith	Arg1:T2	Arg2:T3
R7	isAssociatedWith	Arg1:T2	Arg2:T4
R8	isAssociatedWith	Arg1:T2	Arg2:T5
R9	isAssociatedWith	Arg1:T3	Arg2:T1
R10	isAssociatedWith	Arg1:T3	Arg2:T2
R11	isAssociatedWith	Arg1:T3	Arg2:T5
R12	isAssociatedWith	Arg1:T4	Arg2:T1
R13	isAssociatedWith	Arg1:T4	Arg2:T2
R14	isAssociatedWith	Arg1:T4	Arg2:T3
R15	isAssociatedWith	Arg1:T5	Arg2:T2
R16	treats	Arg1:T5	Arg2:T4
